Dipharma Francis Srl

Overview

Dipharma Francis Srl is a private pharmaceutical company based in Italy, specializing in the development and manufacture of active pharmaceutical ingredients. With a focus on innovative and sustainable solutions, Dipharma serves a wide range of therapeutic areas, providing high-quality products to customers worldwide.

Therapeutic areas

API / Drug Master Files

Dipharma Francis Srl holds 39 active (51 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CHOLIC ACIDActive2026-02-06
• ETRIPAMILActive2025-11-28
• CHENODEOXYCHOLIC ACIDActive2019-09-30
• PIRFENIDONEActive2018-04-24
• 7-KETOLITHOCHOLIC ACIDActive2018-02-27
• DEXLANSOPRAZOLE ANHYDROUSActive2018-01-19
• EFINACONAZOLEActive2017-08-02
• SELEGILINE BASEActive2017-06-30
• DAPSONEActive2017-06-22
• VORTIOXETINE HYDROBROMIDE MONOHYDRATEActive2017-04-06
• AMINOCAPROIC ACIDActive2016-12-14
• FEXOFENADINE HYDROCHLORIDE USP FORM lActive2014-11-05
• FEXOFENADINE HYDROCHLORIDE USP FORM AActive2014-06-13
• RUFINAMIDE USPActive2012-01-04
• FESOTERODINE FUMARATEActive2011-06-16

Showing 15 of 51 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Dipharma Francis Srl in our records. PharmaTek screens the full directory against live FDA enforcement data.